Moreover, research from the Journal of Obesity has demonstrated that combining GLP-1 agonists with behavioral interventionssuch as dietary changes, physical activity, and psychological supportleads to greater long-term success compared to medication alone
En resumen, GLPura puede ser una pieza til de un enfoque integral para la salud y el bienestar, siempre que se combine con un estilo de vida saludable y se consulte a un profesional ante cualquier duda clnica
placebo), la mayora de ellos (liraglituda, semaglutida SC, dulaglutida, albiglutida y efpeglenatida) han demostrado adems una reduccin de los MACE respecto a placebo, mientras exenatida semanal o semaglutida oral mostraron una tendencia a reducir los MACE
Going forward, the increased focus on preventive care, rise in obesity rates, growing awareness of cardiovascular and weight-loss benefits and expansion of insurance coverage for obesity treatments will drive the growth